70254-74-9

Basic information

• Product Name: Methyl-(2-Methyl-6-nitro-phenyl)-aMine
• Synonyms: Methyl-(2-Methyl-6-nitro-phenyl)-aMine;N,2-dimethyl-6-nitroaniline
• CAS NO: 70254-74-9
• Molecular Formula: C₈H₁₀N₂O₂
• Molecular Weight: 166.1772
• Mol File: 70254-74-9.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Methyl-(2-Methyl-6-nitro-phenyl)-aMine(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl-(2-Methyl-6-nitro-phenyl)-aMine(70254-74-9)
• EPA Substance Registry System: Methyl-(2-Methyl-6-nitro-phenyl)-aMine(70254-74-9)

Safety Data

• Hazardous Substances Data: 70254-74-9(Hazardous Substances Data)

Upstream product

• 611-21-2 N,2-dimethylaniline 
• 7664-93-9 sulfuric acid 
• 156461-85-7 N-methyl-N-nitro-o-toluidine 
• 64-19-7 acetic acid 
• 3970-40-9 2-chloro-3-nitrotoluene 
• 74-89-5 methylamine 
• 437-86-5 2-fluoro-3-nitrotoluene 
• 553-90-2 Dimethyl oxalate 
• 570-24-1 2-Methyl-6-nitroaniline 
• 18102-29-9 2-methyl-6-nitroanisole 
• 74-88-4 methyl iodide 
• 2145-35-9 2-methyl-6-nitrotrifluoroacetanilide 
• 77-78-1 dimethyl sulfate 

Downstream Products

• 945021-49-8 C₉H₁₁N₃ 
• 73902-65-5 N₁,6-dimethylbenzene-1,2-diamine 
• 17583-45-8 1,7-dimethyl-1H-benzo[d]imidazole 

Relevant articles and documents

Cu-Catalyzed C-H Allylation of Benzimidazoles with Allenes

CuH-catalyzed intramolecular cyclization and intermolecular allylation of benzimidazoles with allenes have been described. The reaction proceeded smoothly with the catalytic system of Cu(OAc)2/Xantphos and catalytic amount of (MeO)2MeSiH. This protocol features mild reaction conditions and a good tolerance of substrates bearing electron-withdrawing, electron-donating, or electron-neutral groups. A new catalytic mechanism was proposed for this copper hydride catalytic system.

Bicyclic Benzimidazole Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators

Compounds of Formula I: wherein A, B, D, L, R1, R2, R3, R4, m, and n are as defined for Formula I in the description. The invention also relates to processes for the preparation of the compounds and to new intermediates employed in the preparation, pharmaceutical compositions containing the compounds, and to the use of the compounds in therapy.

2-IMINO-BENZIMIDAZOLES

Novel compounds of Formula (I) or pharmaceutically acceptable salts, prodrugs and biologically active metabolites thereof of Formula (I), wherein the substituents are as defined herein, which are useful as therapeutic agents.